REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,541,000 | -14.7% | 1,462,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,806,000 | -27.6% | 1,462,000 | -45.0% | 0.00% | 0.0% |
| Q4 2022 | $2,494,000 | -10.3% | 2,660,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,780,000 | +1.2% | 2,660,000 | -15.5% | 0.00% | 0.0% |
| Q2 2022 | $2,747,000 | -11.9% | 3,148,000 | -5.5% | 0.00% | 0.0% |
| Q1 2022 | $3,118,000 | -12.0% | 3,332,000 | -17.7% | 0.00% | 0.0% |
| Q4 2021 | $3,544,000 | -37.5% | 4,047,000 | -17.9% | 0.00% | 0.0% |
| Q3 2021 | $5,669,000 | -1.5% | 4,932,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $5,754,000 | +5.2% | 4,932,000 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $5,471,000 | – | 4,882,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |